Sarepta Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 58.8M |
| FY2018 | 66.3M |
| FY2019 | 73.6M |
| FY2020 | 78.0M |
| FY2021 | 81.3M |
| FY2022 | 87.6M |
| FY2023 | 92.4M |
| FY2024 | 107.9M |
| FY2025 | 100.1M |
| FY2026 | 105.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 58.8M |
| FY2018 | 66.3M |
| FY2019 | 73.6M |
| FY2020 | 78.0M |
| FY2021 | 81.3M |
| FY2022 | 87.6M |
| FY2023 | 92.4M |
| FY2024 | 107.9M |
| FY2025 | 100.1M |
| FY2026 | 105.0M |